Latest filing published 03 Jun 2025 for NewAmsterdam Pharma Co N.V..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael F. Marino III: trading record in brief
Michael F. Marino III, listed as senior executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in OptiNose, Inc., Nupathe Inc. and NewAmsterdam Pharma Co N.V. Between 7 January 2013 and 1 June 2025, the trades on record add up to 55 filings.
The open-market side counts 10 purchases for €42k alongside 22 sales for €201k. Sales outweigh purchases by €159k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 20 share grants. In 2025 alone, the filings show no purchases and 2 sales.
The median purchase comes to €4,276. The 10 purchases reviewed show no overlap with other insiders buying the same stock within a month.
Most recently, on 3 June 2025, the filings show a share grant in NewAmsterdam Pharma Co N.V. The last insider purchase was made public on 9 September 2020, 2,251 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael F. Marino III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 55,000 sharesOrdinary SharesSEC:0000950170-25-081087:0
- 125,204 sharesCommon StockSEC:0001104659-25-051350:0
- 246 shares@ US$5.611.4% of flowCommon StockSEC:0001494650-25-000040:0
- 2,145 shares@ US$5.2911.8% of flowCommon StockSEC:0001494650-25-000026:0
- 21,150 shares0Common StockSEC:0001494650-25-000009:0
- 3,050 shares@ US$0.441.4% of flowCommon StockSEC:0001494650-24-000172:0
- 3,226 shares@ US$0.872.7% of flowCommon StockSEC:0001494650-24-000132:0
- 49,408 shares@ US$1.1455.9% of flowCommon StockSEC:0001494650-24-000112:0
- 2,946 shares@ US$1.193.5% of flowCommon StockSEC:0001494650-24-000097:0
- 3,267 shares@ US$1.191.4% of flowCommon StockSEC:0001494650-24-000095:1
- 3,817 shares0Common StockSEC:0001494650-24-000095:0
- 15,059 shares@ US$1.8810.3% of flowCommon StockSEC:0001494650-24-000036:1
- 3,816 shares0Common StockSEC:0001494650-24-000036:0
- 280,000 shares0Common StockSEC:0001494650-24-000010:0
- 5,005 shares@ US$1.152.1% of flowCommon StockSEC:0001494650-23-000101:1
- 3,817 shares0Common StockSEC:0001494650-23-000101:0
- 4,991 shares@ US$1.372.5% of flowCommon StockSEC:0001494650-23-000089:1
- 3,817 shares0Common StockSEC:0001494650-23-000089:0
- 1,516 shares@ US$1.150.6% of flowCommon StockSEC:0001494650-23-000071:1
- 3,816 shares0Common StockSEC:0001494650-23-000071:0
- 4,972 shares@ US$1.793.3% of flowCommon StockSEC:0001494650-23-000030:1
- 3,817 shares0Common StockSEC:0001494650-23-000030:0
- 154,375 shares0Common StockSEC:0001494650-23-000026:0
- 5,241 shares@ US$1.779.3% of flowCommon StockSEC:0001494650-23-000006:0
- 2,751 shares@ US$1.691.7% of flowCommon StockSEC:0001494650-22-000144:1
25 of 53 declarations
